← FDA Drug Approvals (Drugs@FDA)

COSENTYX

BLA · Biologics License Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2023-10-06

Drug application

FDA Application #

BLA761349

Application type

Biologics License Application

Brand name

COSENTYX

Generic name

SECUKINUMAB

Active ingredients

SECUKINUMAB

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

NOVARTIS PHARMS CORP

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2023-10-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown